DrugCite
Search

DOXAZOSIN MESYLATE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Doxazosin Mesylate Adverse Events Reported to the FDA Over Time

How are Doxazosin Mesylate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Doxazosin Mesylate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Doxazosin Mesylate is flagged as the suspect drug causing the adverse event.

Most Common Doxazosin Mesylate Adverse Events Reported to the FDA

What are the most common Doxazosin Mesylate adverse events reported to the FDA?

Dizziness
164 (2.16%)
Hypotension
160 (2.1%)
Drug Interaction
125 (1.64%)
Drug Ineffective
114 (1.5%)
Syncope
114 (1.5%)
Hypertension
98 (1.29%)
Loss Of Consciousness
90 (1.18%)
Dyspnoea
89 (1.17%)
Fall
85 (1.12%)
Fatigue
76 (1%)
Orthostatic Hypotension
76 (1%)
Show More Show More
Blood Pressure Increased
73 (.96%)
Nausea
65 (.85%)
Asthenia
64 (.84%)
Headache
63 (.83%)
Blood Pressure Decreased
58 (.76%)
Vomiting
55 (.72%)
Malaise
54 (.71%)
Oedema Peripheral
49 (.64%)
Renal Failure Acute
49 (.64%)
Diarrhoea
43 (.57%)
Vision Blurred
42 (.55%)
Bradycardia
40 (.53%)
Floppy Iris Syndrome
39 (.51%)
Pneumonia
39 (.51%)
Anxiety
38 (.5%)
Blood Creatinine Increased
38 (.5%)
Blood Pressure Systolic Increased
38 (.5%)
Atrial Fibrillation
37 (.49%)
Cardiac Failure
36 (.47%)
Completed Suicide
36 (.47%)
Condition Aggravated
35 (.46%)
Hypoglycaemia
35 (.46%)
Abdominal Pain Upper
34 (.45%)
Cough
34 (.45%)
Palpitations
34 (.45%)
Dehydration
33 (.43%)
Gait Disturbance
33 (.43%)
Suicide Attempt
33 (.43%)
Hypoxia
32 (.42%)
Death
30 (.39%)
Pyrexia
30 (.39%)
Somnolence
30 (.39%)
Thrombocytopenia
29 (.38%)
Myalgia
28 (.37%)
Renal Failure
28 (.37%)
Renal Impairment
28 (.37%)
Blood Pressure Inadequately Control...
27 (.35%)
Heart Rate Increased
27 (.35%)
Pain
27 (.35%)
Pulmonary Oedema
27 (.35%)
Tremor
27 (.35%)
Arthralgia
26 (.34%)
Presyncope
26 (.34%)
Cerebrovascular Accident
25 (.33%)
Chest Pain
25 (.33%)
Dysuria
25 (.33%)
Overdose
25 (.33%)
Pain In Extremity
25 (.33%)
Prostate Cancer
25 (.33%)
Weight Decreased
25 (.33%)
Myocardial Infarction
24 (.32%)
Shock
24 (.32%)
Blood Urea Increased
22 (.29%)
Cardiac Arrest
22 (.29%)
Feeling Abnormal
22 (.29%)
Oedema
22 (.29%)
Pleural Effusion
22 (.29%)
Abdominal Pain
21 (.28%)
Benign Prostatic Hyperplasia
21 (.28%)
C-reactive Protein Increased
21 (.28%)
Constipation
21 (.28%)
Nocturia
21 (.28%)
Pancreatitis Acute
21 (.28%)
Platelet Count Decreased
21 (.28%)
Pollakiuria
21 (.28%)
Abdominal Distension
20 (.26%)
Haemodialysis
20 (.26%)
Rhabdomyolysis
20 (.26%)
Drug Effect Decreased
19 (.25%)
Paraesthesia
19 (.25%)
Rash
19 (.25%)
Sinus Bradycardia
19 (.25%)
Urinary Retention
19 (.25%)
Anaemia
18 (.24%)
Angina Pectoris
18 (.24%)
Back Pain
18 (.24%)
Dry Mouth
18 (.24%)
Haemoglobin Decreased
18 (.24%)
Insomnia
18 (.24%)
Muscle Spasms
18 (.24%)
Nephrotic Syndrome
18 (.24%)
Renal Disorder
18 (.24%)
Cardiac Failure Congestive
17 (.22%)
Cataract
17 (.22%)
Drug Hypersensitivity
17 (.22%)
Erectile Dysfunction
17 (.22%)
Hyperhidrosis
17 (.22%)
Lethargy
17 (.22%)
Medication Error
17 (.22%)
Metabolic Acidosis
17 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Doxazosin Mesylate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Doxazosin Mesylate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Doxazosin Mesylate

What are the most common Doxazosin Mesylate adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Doxazosin Mesylate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Doxazosin Mesylate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Doxazosin Mesylate According to Those Reporting Adverse Events

Why are people taking Doxazosin Mesylate, according to those reporting adverse events to the FDA?

Hypertension
1912
Product Used For Unknown Indication
442
Benign Prostatic Hyperplasia
426
Drug Use For Unknown Indication
408
Blood Pressure
115
Prostatic Disorder
111
Show More Show More
Ill-defined Disorder
85
Blood Pressure Increased
55
Essential Hypertension
40
Prostatomegaly
36
Cardiac Disorder
28
Dysuria
20
Urinary Retention
16
Pollakiuria
15
Atrial Fibrillation
15
Prostatic Adenoma
14
Prostatitis
11
Blood Pressure Management
11
Myocardial Ischaemia
10
Urinary Tract Disorder
10
Bladder Disorder
10
Prostate Examination Abnormal
10
Renal Hypertension
9
Prostate Cancer
9
Nocturia
9
Metastatic Renal Cell Carcinoma
8
Renovascular Hypertension
8
Prostatism
7
Suicide Attempt
7
Urine Flow Decreased
6
Renal Failure
6
Cardiac Failure
6
Intentional Overdose
5
Urinary Incontinence
5
Cardiovascular Disorder
5
Micturition Urgency
5
Blood Pressure Abnormal
5
Coronary Artery Disease
5
Urogenital Disorder
4
Hypertonic Bladder
4
Unevaluable Event
4
Prostatectomy
4
Micturition Disorder
4
Urinary Tract Infection
4
Prophylaxis
3
Neurogenic Bladder
3
Pain
3
Hypertensive Heart Disease
3
Malignant Hypertension
3
Adenoma Benign
3
Phaeochromocytoma
3

Drug Labels

LabelLabelerEffective
Doxazosin MesylateDAVA Pharmaceuticals, Inc.09-FEB-10
CarduraRoerig24-MAR-10
Doxazosin MesylateState of Florida DOH Central Pharmacy25-MAY-10
Doxazosin Mesylate REMEDYREPACK INC. 29-JUL-10
Doxazosin MesylateMajor Pharmaceuticals12-OCT-10
Doxazosin MesylateREMEDYREPACK INC. 31-MAR-11
Doxazosin MesylateREMEDYREPACK INC. 09-MAY-11
Doxazosin MesylateREMEDYREPACK INC. 06-JUN-11
Doxazosin MesylateGolden State Medical Supply, Inc.01-JUL-11
CarduraxlRoerig20-JUL-11
Doxazosin MesylateREMEDYREPACK INC. 16-NOV-11

Doxazosin Mesylate Case Reports

What Doxazosin Mesylate safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Doxazosin Mesylate. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Doxazosin Mesylate.